Israel VC Funds

New Venture Partners is a global venture capital firm that specializes in transforming corporate R&D assets into standalone businesses. The firm focuses on leveraging cutting-edge innovations from large technology companies and spinning them out into independent ventures. With a unique approach, New Venture Partners works closely with corporate partners to identify high-potential technologies that may not align with the company's core business but have significant market opportunities. The firm invests primarily in sectors such as telecommunications, IT, semiconductors, and digital media, emphasizing deep tech and transformative innovations. Their portfolio includes companies that emerged from major R&D labs, such as Bell Labs and British Telecom, showcasing their expertise in corporate spinouts. New Venture Partners typically invests in early-stage startups, guiding them from the incubation phase through to commercialization. Their team brings a wealth of experience from both the corporate and entrepreneurial worlds, providing a mix of strategic guidance and operational support to help ventures scale. With offices in the U.S. and Europe, New Venture Partners has a global reach and focuses on markets across both continents. Their strategy revolves around aligning with corporate partners to unlock the commercial potential of underutilized technologies, ultimately creating high-value businesses that deliver strong financial returns. The firm has established a reputation as a leader in corporate venture capital, with a track record of successful exits and long-term value creation.

Next Gear Ventures (NGV) is an early-stage venture capital fund based in Tel Aviv, focused on investing in smart mobility, energy, and sustainability sectors. The firm primarily targets Israeli startups but also supports companies in Europe and the U.S. NGV is dedicated to nurturing world-changing innovations, emphasizing ventures that contribute to a greener, safer future for transportation. NGV is known for more than just providing capital; they offer a comprehensive ecosystem of resources and connections through their partnership with Drive TLV, an innovation hub that accelerates the growth of startups in the smart mobility space. This partnership allows NGV-backed companies to gain valuable market insights and strategic connections early on, enhancing their chances of success. The fund has a track record of successful exits, including companies like Midnight Robotics and Exo Technologies. NGV typically invests between $100,000 and $2.5 million in early-stage companies, focusing on building long-term partnerships with founders rather than seeking quick exits. Their investments prioritize finding product-market fit and scaling solutions with global impact, particularly in sectors that improve the quality of life and environmental sustainability​.

Credit Suisse Entrepreneur Capital Ltd., established in 2010, is the venture capital arm of Credit Suisse based in Zurich, Switzerland. The firm focuses on investing in innovative small and medium-sized enterprises (SMEs) and startups across various sectors, including robotics, automation, medtech, and fintech. To date, Credit Suisse Entrepreneur Capital has invested around CHF 130 million in over 50 companies, and recently expanded its fund by an additional CHF 70 million, bringing the total to CHF 200 million. Notable investments from Credit Suisse Entrepreneur Capital include Perspective Robotics (d.b.a. Fotokite), a Zurich-based startup specializing in tethered drones that improve the safety and efficiency of public safety operations, and Ava, a company in the monitoring equipment sector. These investments highlight the firm’s commitment to supporting high-potential technologies and innovative business models. Credit Suisse's venture capital efforts are part of a broader strategy to support Switzerland's entrepreneurial ecosystem, ensuring the country remains a global leader in innovation and business. For more information about their investments and strategic approach, you can visit their official website.

NFX, founded in 2015 and headquartered in San Francisco, is a venture capital firm that specializes in early-stage investments. The firm is renowned for its focus on network effects, which it believes are crucial for building market-transforming companies. NFX invests in a diverse range of sectors, including AI, biotech, fintech, gaming, enterprise software, marketplaces, and crypto, with a particular focus on Silicon Valley and Israel. Notable investments by NFX include companies like DoorDash, Lyft, Patreon, and Houseparty. The firm has made a total of 577 investments and has seen significant exits such as Similarweb and CircleUp. NFX's unique approach involves deeply understanding and leveraging network effects, which it views as essential for startups to compete effectively in today's market​​. The firm was co-founded by James Currier, Pete Flint, Gigi Levy-Weiss, and Stan Chudnovsky, who bring extensive entrepreneurial and investment experience. NFX supports its portfolio companies through The Guild, an active community of over 200 founders who share KPIs, insights, and access to foster mutual growth and success​. NFX aims to transform how true innovators are funded, providing not just capital but also strategic guidance to help startups build sustainable and disruptive businesses​.

Nina Capital is a specialized venture capital firm based in Barcelona, focusing on early-stage investments in health technology. Founded by Marta Gaia Zanchi, the firm invests across Europe, the United States, Canada, Israel, and Australia. Nina Capital leverages the Biodesign process from Stanford, which emphasizes a need-driven and value-based approach to healthcare innovation. Their investment strategy spans pre-seed to seed stages, with typical investment sizes ranging from €200k to €1.5m​. The firm supports startups that apply advanced data science, engineering innovation, and IT-enabled products to solve healthcare challenges. Notable portfolio companies include QuantHealth, which uses AI to predict patient responses in clinical trials, and Cardiomatics, offering automated ECG interpretation to improve healthcare efficiency​. The core team, led by principals like Anastassiou and Yahel Halamish, combines deep expertise in healthcare, technology, and investment. They are committed to diversity and multidisciplinary collaboration, fostering an inclusive environment that promotes innovative solutions to complex healthcare problems.

North Bridge Venture Partners, founded in 1994 and based in Wellesley, Massachusetts, is a venture capital firm that provides seed-to-growth financing. The firm focuses on several key sectors, including communications and infrastructure, software, materials, healthcare, and digital media. North Bridge Venture Partners supports companies from their initial stages through to becoming market leaders, leveraging a combination of operational experience and strategic guidance​. The firm has made over 479 investments and has achieved 183 exits. Notable portfolio companies include Couchbase, Markforged, and Lyra Therapeutics. North Bridge has a significant presence in the U.S. market, focusing primarily on early-stage and growth-stage companies operating in healthcare and information technology sectors​. North Bridge is led by a team of experienced professionals, including founder and managing partner Edward Anderson and general partners Richard D'Amore and Jeffrey McCarthy. The firm's strategy emphasizes investing in exceptional entrepreneurs whose ideas have the potential to disrupt their respective industries.

New Venture Fund (Norwest Venture Partners) is a leading venture capital and growth equity investment firm with a diversified investment strategy. It focuses on early- to late-stage investments across various sectors, including consumer, enterprise, and healthcare. Norwest has a robust global presence with offices in North America, India, and Israel, enabling it to identify and support innovative companies worldwide. Notable investments by Norwest include companies like Dave, Gong, Swiggy, Udemy, Vuori, and Ritual. These investments demonstrate the firm's commitment to backing visionary leaders and transformative businesses. Norwest’s investment strategy includes providing not only capital but also strategic guidance and operational support to help portfolio companies scale and achieve significant growth. The firm has recently launched its $3 billion fund, NVP XVI, to continue empowering high-impact businesses. In recent years, Norwest has expanded its focus within the healthcare sector to include biotechnology, building on its successes in medical devices, diagnostics, and healthcare services. Norwest's notable exits include companies such as Opendoor, Talkspace, Udemy, Aporeto, CyberX, and Shape Security, among others. The firm is also committed to environmental, social, and governance (ESG) principles, investing in companies that prioritize sustainability and social impact​.

Nutreco is a global leader in animal nutrition and aquafeed, committed to sustainably feeding the growing global population. Headquartered in the Netherlands, Nutreco operates through two primary business lines: Skretting, which focuses on aquaculture, and Trouw Nutrition, which serves the livestock industry. The company’s overarching mission, known as "Feeding the Future," is to drive sustainability across the entire food production chain. Nutreco's strategy is centered around three main areas: supporting sustainable production through technology, advancing nutrition and animal health, and sourcing future protein ingredients. The company is heavily invested in developing sustainable alternatives to traditional feed ingredients, including the use of insect protein and other novel sources. This approach aims to reduce the environmental footprint of animal farming, which is crucial as feed ingredient production currently accounts for a significant portion of greenhouse gas emissions in the livestock industry. Innovation is a key pillar of Nutreco's operations, primarily driven by their NuFrontiers team, which focuses on breakthrough technologies that can transform the protein value chain. Nutreco has also been expanding its production capabilities in growth markets like Asia and Latin America, as well as optimizing its operations to increase agility and reduce costs. The company’s investments are aimed at not just expanding its market presence but also ensuring that its products and practices are aligned with global sustainability goals, making it a crucial player in the future of food production​.

Oak Investment Partners is a leading multi-stage venture capital firm that focuses on high-growth opportunities across several sectors, including information technology, financial services technology, healthcare, and clean energy. Founded in 1978, Oak has invested over $9 billion in more than 525 companies worldwide. The firm is known for its hands-on approach, offering comprehensive support and strategic assistance through its extensive network of industry experts. Oak's portfolio includes notable companies such as Castlight Health, Zayo Group, Kayak, Benefitfocus, and Protean Electric, among others. Their investment strategy spans early to late-stage investments, including growth equity and PIPE (private investment in public equity) investments. Oak Investment Partners has built a reputation for its ability to identify transformative opportunities and support them through long-term, steady guidance​. The firm is headquartered in Norwalk, Connecticut, with additional offices in California. The team includes experienced professionals like Managing Partners Bandel Carano, Ed Glassmeyer, Fred Harman, and Ann Lamont, who bring deep domain expertise and a consistent investment philosophy to the table​.

Ocean 14 Capital is a private equity firm dedicated to transforming the "blue economy," with a strong focus on addressing environmental challenges while generating competitive financial returns. Established in 2020, the firm primarily invests in sectors like sustainable aquaculture, alternative proteins, circular plastics, and ocean conservation technologies. Its mission aligns with the United Nations’ Sustainable Development Goal 14 (SDG 14), which aims to conserve and sustainably use ocean resources​. The firm has successfully raised €200 million for its first fund, attracting cornerstone investors such as the European Investment Fund (EIF), Minderoo Foundation, and Chr. Augustinus Fabrikker. Ocean 14’s investment strategy targets companies with innovations that protect marine ecosystems and promote food security, such as SyAqua (shrimp genetics and nutrition) and AION (a circular plastics service)​. Ocean 14 seeks to drive sustainable growth in the blue economy, a sector expected to reach $3 trillion by 2030. They aim to invest in 20-25 companies, with an emphasis on scalable technologies that offer both environmental impact and financial returns​.

OCV Partners is a Los Angeles-based venture capital firm, established with a mission to invest in companies that demonstrate significant growth potential, primarily in the technology and healthcare sectors. Their investment strategy is focused on mid- to late-stage companies, often in fields such as SaaS, fintech, biotech, and digital health. With a portfolio that includes innovative firms like Jukin Media, Scopely, and TaskUs, OCV Partners has positioned itself as a hands-on investor, providing both capital and operational support to help scale high-growth companies​. The firm prides itself on its diverse expertise, backing founders through every phase of their business journey. The OCV team brings decades of experience in building and scaling companies across various industries, from software and financial services to healthcare and media. They partner with startups not just to provide financial backing, but also to offer operational insight, helping businesses navigate the complexities of scaling. OCV Partners is well-known for its long-term mindset, focusing on building sustainable value through innovation and strong partnerships. The firm typically invests in companies at the seed to Series B stages, though they remain flexible and open to later-stage opportunities when appropriate.

Odey Asset Management, once a prominent name in the investment industry, is currently undergoing significant changes as it winds down its operations. Founded by Crispin Odey in 1991, the firm became known for its high-conviction, often contrarian investment strategies, and managed substantial assets across various funds. However, recent developments have led to the closure of the firm, including its subsidiaries such as Brook Asset Management and Odey Wealth. As part of the wind-down process, Odey Asset Management is in the midst of transferring its fund management responsibilities to new asset managers. This transition aims to ensure continuity for investors, allowing for a smoother handover of the funds under its management. The firm is working closely with regulatory authorities to manage this transition in a way that protects the interests of its clients. For investors and clients, the firm’s website provides the most up-to-date information regarding the ongoing closure and transfer of assets. Detailed statements and guidance are available to help investors navigate this period of change, offering insights into how their investments will be managed moving forward. The closure marks the end of an era for Odey Asset Management, which had been a significant player in the global investment landscape for over three decades. Despite its current challenges, the firm’s legacy in shaping high-risk, high-reward investment strategies remains noteworthy.

OTV (formerly Olive Tree Ventures) is a global venture capital firm specializing in digital health startups. Founded in 2015, OTV is based in Tel Aviv and New York, with additional offices in China to support its expansion into the Asia-Pacific market. The firm focuses on mid-growth stage companies developing cutting-edge digital health technologies that aim to revolutionize healthcare globally. OTV’s mission is to back innovative entrepreneurs who are building impactful solutions that address significant healthcare challenges. The firm’s $170 million fund is geared toward investing in companies offering groundbreaking technologies in telemedicine, genomics, AI-driven health platforms, and more. Notable portfolio companies include TytoCare, Lemonaid Health, and Scopio Labs, which are leaders in telehealth and healthcare innovation. OTV’s portfolio reflects its commitment to improving healthcare outcomes through technological advancement. With a leadership team boasting decades of experience in healthcare, technology, and private equity, OTV provides more than just capital. The firm actively supports its portfolio companies in scaling their businesses and navigating complex regulatory environments. By bridging innovation from the West with opportunities in North America, Israel, and Asia, OTV is uniquely positioned to help startups thrive in the growing global digital health market.

Omnes Capital is a leading European private equity firm specializing in energy transition and innovation. Founded in 1999 and based in Paris, Omnes manages over €5 billion in assets. The firm's investment strategy focuses on four core areas: renewable energy, sustainable cities, deep tech venture capital, and co-investment. Notable investments include Direct Energie, Neoen, and BioSerenity. Omnes has made significant strides in the renewable energy sector with its Capenergie funds, which have invested over €2.5 billion across more than 60 projects in Europe, transforming developers into independent power producers. For example, their Capenergie 2 fund achieved a 15% net IRR, ranking among the top performers in Europe. Omnes also plays a crucial role in sustainable urban development by financing projects that support decarbonization and resilient city infrastructure. Their deep tech investments focus on disruptive technologies and startups pushing the boundaries of innovation. In addition to financial returns, Omnes is committed to responsible investment practices. The firm supports non-profits through the Omnes Foundation, which focuses on education, health, and social integration for children. Omnes is also a signatory of the United Nations Principles for Responsible Investment (PRI), underscoring their commitment to sustainability and ethical investment​.

Opera Tech Ventures is a Paris-based venture capital firm launched in 2018 as the investment arm of BNP Paribas. Specializing in fintech, insurtech, AI, sustainability tech, and enterprise software, Opera Tech Ventures targets startups with cutting-edge solutions in these sectors. They predominantly invest in Series A to D rounds, with a focus on scalable technologies that address critical market needs. The firm typically invests between $3 million and $15 million per deal, often taking a leadership role in the funding process. Their portfolio includes companies like SESAMm, an AI-driven analytics firm, Stoik in cloud security, and Arbol in commercial insurance. With a global scope, Opera Tech Ventures invests across Europe and North America, particularly favoring markets in France, the UK, the US, and the Netherlands. Their investment strategy is driven by a deep understanding of fintech and enterprise solutions, looking for startups that can revolutionize industries and show strong growth potential. Co-investing with well-known partners like Andreessen Horowitz and Munich Re Ventures, Opera Tech Ventures ensures their portfolio companies receive both capital and strategic guidance​. Under the leadership of Thibaut Schlaeppi, the firm is highly engaged in supporting portfolio companies beyond just financial backing. They offer insights, mentorship, and extensive connections across industries. Their diverse team brings expertise from multiple sectors, allowing them to help companies scale effectively in highly competitive markets. By focusing on innovation, Opera Tech Ventures continues to build a robust portfolio of future-leading companies.

Optum Ventures is a prominent venture capital firm focused on transforming healthcare through strategic investments in innovative digital health startups. Notable portfolio companies include Buoy Health, which uses AI to guide patients in understanding symptoms, and Mindstrong Health, which leverages AI to diagnose and treat neuropsychiatric disorders through smartphone interactions. Other significant investments include Dispatch Health, which provides in-home medical care, and Equip, specializing in virtual eating disorder treatments. Optum Ventures primarily invests in early to growth-stage companies that utilize data-driven technologies to improve healthcare delivery, access, and payment systems. Their geographic focus spans the United States and international markets, reflecting a commitment to global healthcare innovation. The fund's strategy emphasizes partnering with startups to provide not just capital, but also access to Optum's extensive healthcare expertise and market presence. They typically lead investment rounds and are highly involved in guiding the strategic direction of their portfolio companies. Key team members include Larry Renfro, Managing Partner, who brings extensive experience from UnitedHealth Group, and Vijay Barathan, who focuses on digital health investments. The team is based across major hubs in the US and Europe, ensuring a diverse and comprehensive approach to investment and support.

Orange Ventures, the venture capital arm of the Orange Group, operates with a fund allocation of €350 million. This fund focuses on strategic areas of interest such as Networks & IT, Digital Enterprise, Cybersecurity, and Fintech, as well as exploring new territories like e-health, gaming, and consumer platforms. Orange Ventures targets startups across various stages of maturity, from seed-stage companies in the Middle East and Africa to more mature companies in Europe and the US. Their investments typically range up to €20 million per round, and they emphasize creating synergies between their portfolio companies and Orange's extensive network and customer base​. Their portfolio includes a diverse range of companies such as Dataiku, a leading AI platform, and Brut, a global media brand for millennials and Gen Z. Orange Ventures aims to promote technological champions that support a digital and responsible world, leveraging the Orange Group’s business expertise and customer reach.

Orbia Ventures is the corporate venture capital arm of Orbia, a multinational company focused on advancing life globally. Orbia Ventures supports startups developing groundbreaking solutions in areas like climate tech, decarbonization, sustainability, circular economy, food security, water infrastructure, data access, and energy storage. With a strong commitment to addressing the world's biggest challenges, Orbia Ventures invests in early- and growth-stage companies that align with its mission to create resilient and future-fit communities. The firm provides more than just capital; it offers extensive business development support, operational expertise, and opportunities for commercial collaborations within Orbia’s broader network. Orbia Ventures helps build strong management teams and leverages its relationships to open new business opportunities for portfolio companies. Notable investments include Tortuga AgTech, which uses advanced robotics to enhance agricultural productivity, Verdagy, a leader in green hydrogen production, and Ascend Elements, which focuses on recycling lithium-ion batteries to create advanced battery materials. Other standout portfolio companies include Type One Energy (fusion energy), Deepomatic (AI-powered visual automation), and Greeneye Technology (precision agriculture). These companies reflect Orbia Ventures' commitment to driving impactful innovation across critical sectors.

Origins Fund is a unique venture capital firm that specializes in backing consumer technology startups from pre-seed to Series A. What sets Origins apart is its strategy of combining financial investment with the power of social influence. The fund's limited partners include high-profile athletes and celebrities who collectively have over 160 million social media followers. This provides an "unfair advantage" to the startups in its portfolio by significantly boosting their visibility and growth potential. Origins typically invests between $100,000 and $500,000 per startup and reserves additional capital for follow-on investments in the most promising companies. The fund focuses on category-defining consumer businesses, particularly those that can benefit from the massive influence and reach of its celebrity LPs. The fund's co-founders, including former French football star Blaise Matuidi, are based in global hubs like Miami, New York, and Paris, allowing Origins to maintain a diverse and internationally connected portfolio. Notable investments include companies like Upway, a marketplace for reconditioned e-bikes, and Moka.care, a corporate mental health solution.

OurCrowd, founded in 2013 and headquartered in Jerusalem, is a leading global venture capital platform. It offers accredited investors access to pre-vetted startups, exclusive venture funds, and alternative investments. The firm’s portfolio covers sectors such as healthcare, AI, robotics, energy, and fintech, with notable investments in Beyond Meat, JumpCloud, and Lemonade. Beyond Meat, a leader in plant-based foods, and Lemonade, an AI-driven insurance company, both had successful IPOs and continue to thrive. OurCrowd’s investment strategy involves thorough due diligence and active support for portfolio companies, ranging from seed to growth stages. They typically invest between $1 million and $5 million, offering strategic guidance and access to a global network of co-investors and operational support​. The firm operates globally, with a strong presence in Israel and the U.S., and investments in Europe, Asia, and Latin America. This global reach allows them to tap into diverse markets and innovative ecosystems. Led by CEO Jon Medved, OurCrowd’s team includes investment professionals across multiple offices worldwide, ensuring a comprehensive approach to emerging technologies and market opportunities. Startups seeking investment should highlight their innovation, scalability, and market potential, approaching OurCrowd through their network or platform to increase funding chances

Oxx VC is a venture capital firm specializing in B2B SaaS investments, focusing on scale-up stage companies in Europe and Israel. Founded in 2017, Oxx operates from London and Stockholm, providing essential growth capital and strategic resources to help companies achieve explosive growth. Notable investments by Oxx include Peak, a SaaS company leveraging AI for decision intelligence; Funnel, which offers marketing data hub solutions; and Codility, a platform for technical hiring. These investments highlight Oxx's commitment to supporting innovative software companies that have achieved product-market fit and are ready to scale. Oxx recently closed its second fund at €172 million, backed by institutional investors such as British Patient Capital, Saminvest, KfW Capital, and Argentum. This fund will continue to support SaaS companies through growth stages, particularly those focusing on AI-driven innovations. The firm, led by co-founders Richard Anton and Mikael Johnsson, prides itself on a selective, evidence-based investment approach, providing tailored support to each portfolio company. Oxx's mission is to help build global category leaders in the SaaS sector by combining deep industry knowledge, a strong network, and hands-on partnership.

Panakès Partners, based in Milan, is a leading venture capital firm specializing in life sciences. Founded by Diana Saraceni, who has over 20 years of experience in the VC industry, the firm focuses on early-stage startups and SMEs developing innovative technologies in biotech, diagnostics, and medical devices. Their portfolio includes notable investments like EndoStart and Diadem, reflecting their commitment to groundbreaking solutions in healthcare. Panakès primarily targets Europe and Israel, aiming to address significant unmet medical needs with a robust ESG framework. Their latest €175 million fund, the Purple Fund, emphasizes Series A investments, supporting around 15-18 companies with average checks ranging from €5 to €10 million. Known for leading rounds, Panakès actively engages with startups through a rigorous selection process, valuing sustainability and impactful health solutions. The team, led by Saraceni, brings extensive expertise and a strong network in the life sciences sector, bolstered by their participation in various national and international advisory boards. For entrepreneurs, Panakès is approachable via direct submissions to their email, fostering a transparent and accessible investment process.

Pangaea Ventures is a leading venture capital firm specializing in hard tech and impact investments. Focused on leveraging advancements in materials science, chemistry, and biology, Pangaea Ventures invests in startups addressing global challenges like climate change, food security, and human health. Their portfolio includes innovative companies such as CarbonCure, Aspect Biosystems, and NewLeaf Symbiotics, which are pioneering solutions in carbon sequestration, bioprinted tissues, and sustainable agriculture, respectively. With a geographic focus on North America, Pangaea Ventures typically invests in early to growth-stage companies. Their investment strategy centers around creating measurable impact, often leading investment rounds with significant capital. They are particularly interested in startups that can demonstrate clear, scalable solutions to critical environmental and health problems. Pangaea Ventures' team, based in Vancouver, Scottsdale, and Hillsborough, includes experts like General Partner Chris Erickson, who bring extensive experience in science and business. The firm is known for its rigorous due diligence process and close collaboration with portfolio companies to maximize both financial and impact returns. Startups are encouraged to approach Pangaea with detailed proposals that highlight innovative, market-ready technologies. In summary, Pangaea Ventures is a key player in the venture capital landscape, driving sustainable innovation through strategic investments in transformative technologies.

Pantera Capital is a pioneering venture capital firm focused exclusively on blockchain and cryptocurrency investments. Founded by Dan Morehead in 2003, Pantera launched the first cryptocurrency fund in the U.S. in 2013 when Bitcoin was valued at $65 per BTC. They have since introduced various funds, including the first blockchain-focused venture fund and the first early-stage token fund in 2017. Pantera manages $5.6 billion in assets, providing investors with comprehensive exposure to the blockchain ecosystem through venture equity, early-stage tokens, and liquid tokens. Their investment strategy is global, having backed over 100 blockchain companies and 110 early-stage token deals across sectors like decentralized finance (DeFi), next-gen payment systems, and institutional trading tools. The firm's notable funds include the Pantera Venture Funds, Pantera Bitcoin Fund, Pantera Liquid Token Fund, and the all-encompassing Pantera Blockchain Fund. Their extensive portfolio features key players in the blockchain space, contributing significantly to the industry's infrastructure and growth. Pantera Capital operates from offices in the Bay Area, New York, and Puerto Rico, with a team of seasoned professionals bringing decades of experience from top-tier financial firms and technical backgrounds.

Paradigm Ventures is a prominent venture capital firm that excels in investing within the cryptocurrency and blockchain technology sectors. Their portfolio boasts notable investments such as Coinbase, Chainalysis, and OpenSea, reflecting their strong presence in the digital assets space. They focus on investing in early-stage ventures but also support companies through various growth stages with investment sizes ranging from $1M to $100M. Paradigm's investment strategy is deeply research-driven, often leading rounds and providing significant hands-on support in areas like technical mechanism design, smart contract security, and operational scaling. This approach not only ensures the technological robustness of their portfolio companies but also aids in achieving long-term growth and market leadership. Geographically, Paradigm is heavily invested in the United States, particularly within major tech hubs such as San Francisco. However, their investments and interest span globally, targeting innovative companies that push the boundaries of blockchain technology. Paradigm prefers to be approached by startups with a clear and compelling vision for their technology and its impact on the crypto ecosystem. They are highly selective, looking for teams with strong technical foundations and a demonstrated ability to execute their vision effectively.

PeakBridge VC is a venture capital firm focused on Agri-FoodTech, investing in companies that address major challenges in the global food system. Founded in 2016 and headquartered in Malta, PeakBridge aims to create long-term impact by investing in startups that drive sustainable solutions, improving both environmental and health outcomes across the food chain. The firm’s investment strategy is centered on five key areas: ingredient innovations, alternative protein technologies, food system digitalization, nutrition & health, and alternative farming systems. By investing in these sectors, PeakBridge helps startups scale solutions that tackle issues such as food waste, nutrition deficiencies, and the carbon footprint of food production. Its portfolio includes innovative companies like Standing Ovation (dairy substitutes through microbial fermentation), Vow (cultured meat), and Rival Foods (plant-based protein). PeakBridge operates through its FoodSparks® Seed Fund for early-stage European and Israeli startups, and Growth II Fund for Series A-B investments in Europe, the U.S., and Israel. The firm’s total assets under management exceed $250 million, with significant backing from Edmond de Rothschild Private Equity. As an Article 9 fund under the Sustainable Finance Disclosure Regulation (SFDR), PeakBridge integrates strict ESG principles into its investments, ensuring all portfolio companies contribute to a healthier and more sustainable food system.

Philips Ventures is the venture capital arm of Royal Philips, focusing on early- to growth-stage investments in healthcare technology startups that align with Philips’ mission to improve patient outcomes, reduce healthcare costs, and transform the healthcare experience. Established in 1998 and based in Amsterdam, Philips Ventures invests globally, supporting companies that develop digital health solutions, medical devices, and health technology services. The fund is business-agnostic but emphasizes sectors like digital software, AI-driven health solutions, and technology-enabled services. Philips Ventures provides not just capital but also strategic support, offering startups access to Philips' extensive clinical and regulatory expertise, global market insights, and deep relationships within the healthcare industry. Their investment strategy includes leading or co-leading rounds, with initial investments typically ranging from $2 million to $5 million, and they actively syndicate deals to collaborate with other investors. Philips Ventures also fosters partnerships between their portfolio companies and Philips' various business units, helping startups scale and navigate the complex healthcare landscape. This approach has led to investments in companies like Elucid, Validic, and MIVI Neuroscience, all of which are pushing the boundaries of healthcare innovation.

Phoenix Venture Partners (PVP), established in 2010 and headquartered in San Mateo, California, is a venture capital firm that specializes in investing in early-stage startups with breakthrough materials science innovations. The firm focuses on sectors such as advanced materials, photonics, electronics, and clean technology. Their investment strategy encompasses seed, venture, and growth stages, providing both capital and strategic guidance to drive the commercialization and scalability of innovative technologies​. PVP has a robust portfolio, including companies like Inkbit, which develops advanced additive manufacturing systems, and FIGUR8, which creates wearable musculoskeletal technology. Other notable investments include Agrology, a company in the agriculture biotechnology space, and Ubicept, specializing in computer vision and image recognition​. The firm is led by experienced professionals such as Dr. Frank Levinson, a co-founder and Managing General Partner, who has a strong track record in building advanced materials companies and was the founder of Finisar Corporation. PVP's recent investments highlight their commitment to transformative technologies, with a focus on sectors that have substantial growth potential and societal impact.

Pirveli Ventures is a Montreal-based family fund that focuses on early-stage investments, particularly in Israeli startups. The fund is known for its laid-back, hands-on approach, providing both initial and follow-on investments while actively supporting portfolio companies in areas like strategy, business development, and management. This close involvement allows Pirveli to act as an extension of the startup teams they back. Their investments typically center around sectors such as agricultural tech, health tech, sustainability, and automotive technologies. Notable companies in their portfolio include Gordian Surgical, Eco Wave Power, and Flora Fotonica, reflecting a commitment to innovative, high-impact ventures. Pirveli Ventures generally invests in the seed stage, and while they do not limit themselves to a specific check size, they are comfortable co-investing alongside other funds. Their investment philosophy focuses on working with startups that have a clear business plan and strong management teams, helping them transition from innovative ideas to successful companies​.

Pitango Venture Capital, established in 1993 and based in Herzliya, Israel, is one of the largest and most prominent venture capital firms in Israel, managing over $3 billion across various funds. The firm focuses on investing in early-stage startups through Pitango First, growth-stage companies through Pitango Growth, and health tech innovations through Pitango HealthTech. Pitango has backed a range of notable companies that have become leaders in their respective fields. These include Via Transportation, which has revolutionized urban mobility, Taboola, a significant player in content recommendation and discovery, and Varonis Systems, a cybersecurity company. The firm has also been involved in successful exits, such as the acquisition of Anobit by Apple and the IPO of Radware on NASDAQ. The investment strategy of Pitango emphasizes partnering with visionary entrepreneurs and providing them with the necessary resources and guidance to scale their businesses. The team at Pitango includes experienced professionals like Nechemia (Chemi) Peres and Rami Kalish, who bring a wealth of expertise to the firm’s diverse investment portfolio. Pitango's approach is characterized by a strong commitment to innovation and sustainability, ensuring that the companies they invest in are not only successful but also contribute positively to the broader community. This dedication has positioned Pitango as a key player in both the Israeli and global venture capital ecosystems.

Planet A Ventures, based in Berlin, is a pioneering venture capital fund dedicated to supporting GreenTech startups that drive significant environmental impact. With a first fund of €160 million, Planet A invests primarily in European companies focused on achieving net-zero emissions and promoting sustainability across various sectors including agriculture, energy, manufacturing, and transportation. Notable investments include Makersite, which uses AI to enhance sustainable supply chains, and INERATEC, known for its modular chemical plants producing sustainable fuels. The fund also backs innovative solutions like Wildplastic, which recycles plastic waste, and GA Drilling, which develops geothermal energy technologies. Planet A takes a science-based approach to investing, incorporating life cycle assessments into its due diligence process to ensure each investment's positive impact. This methodology allows their in-house science team to veto investments that don't meet stringent environmental criteria. The fund typically writes initial checks ranging from €500k to €3 million and prefers to lead rounds. Key team members include founders Tobias Seikel, Nick de la Forge, Fridtjof Detzner, Christian Schad, Christoph Gras, and Lena Thiede. Their combined expertise spans investing, entrepreneurship, and environmental science, ensuring a well-rounded support system for portfolio companies. Active engagement with portfolio startups and a commitment to scalable, impactful solutions position Planet A Ventures as a leader in the GreenTech VC space.

Planeteer Capital is a venture capital firm based in New York City that focuses on pre-seed and seed-stage investments in climate tech startups. Founded by Sophie Purdom, a co-founder of Climate Tech VC (CTVC), Planeteer Capital aims to partner with founders who are addressing the challenges of climate change through innovative technologies and solutions. The firm is anchored by an Ivy League endowment and backed by notable investors including Collaborative Fund and former Meta CTO Mike Schroepfer. Planeteer Capital targets sectors such as carbon management, industrial decarbonization, the built environment, climate intelligence and insurance, and sustainable agriculture. The firm’s mission is to empower visionary founders with the necessary capital and network to prove and scale their transformative models. Planeteer Capital distinguishes itself by providing not just financial support, but also strategic guidance and a sophisticated understanding of the climate tech capital stack​​.

Plug and Play Tech Center, headquartered in Sunnyvale, California, is the world’s largest startup accelerator and a leading venture capital firm. Known for its expansive global reach, Plug and Play operates in over 50 locations across five continents. Their notable investments include industry giants like PayPal, Dropbox, and LendingClub, along with a portfolio boasting more than 30 unicorns such as Honey and Guardant Health. Focusing on diverse industries such as fintech, health, insurtech, and supply chain, Plug and Play leverages its robust corporate network of 450 partners to drive innovation. Their investment strategy is characterized by small, pre-seed and seed-stage checks typically ranging from $100,000 to $150,000. They maintain an active presence globally, investing equally in U.S.-based and international startups. The firm's founder and CEO, Saeed Amidi, emphasizes high energy and a global approach to foster entrepreneurship. Key team members like George Damouny play vital roles in maintaining Plug and Play’s status as one of the most active investors worldwide. Plug and Play’s investment approach is unique, often engaging startups through their acceleration programs without necessarily investing in every participant. They focus on building ecosystems around each industry to maximize startup potential. Recently, the firm has made 102 investments in Q1 2023 alone, underscoring its dynamic and proactive investment strategy.

Pontifax Venture Capital is a healthcare-focused venture capital firm based in Herzliya, Israel, founded in 2004. The firm manages approximately $1.2 billion across multiple funds and focuses on identifying and investing in transformative life sciences technologies at all stages of development. Pontifax's portfolio includes around 100 companies that address significant unmet medical needs through groundbreaking innovations​. The firm was co-founded by Eli Hurvitz, a legendary figure in the pharmaceutical industry and former CEO of Teva Pharmaceuticals, alongside Ran Nussbaum and Tomer Kariv. Pontifax takes a hands-on approach with its portfolio companies, providing strategic guidance and leveraging extensive networks to help these companies grow and succeed. Pontifax's investment strategy spans various sectors within the life sciences, including biopharmaceuticals, medical devices, and gene therapy. Notable investments include Kite Pharma, which was acquired by Gilead Sciences, and Eloxx Pharmaceuticals, which focuses on treatments for genetic diseases caused by nonsense mutations.

Presight Capital, founded in 2019 by Christian Angermayer in partnership with Apeiron Investment Group, is a global venture capital firm based in West Hollywood, California. The firm manages over $600 million in assets across two early-stage funds and focuses on investing in biotechnology, consumer, fintech, deep tech, food tech, cryptocurrency, healthcare, and technology sectors. Notable investments by Presight Capital include ATAI Life Sciences, a mental health company using psychedelics; AbCellera, a biotech firm specializing in antibody therapies; and Compass Pathways, which focuses on mental health treatments using psilocybin. Other prominent companies in their portfolio are General Fusion, EnergyVault, and Perfect Day, which produces lab-grown dairy products. Presight Capital aims to support ambitious founders by providing capital, connections, and strategic advice. They invest in various stages, from seed to IPO, and have a diverse portfolio that includes companies like Razor Group, Syfe, and Alto Neuroscience. The firm's approach is characterized by a strong emphasis on transformative technologies and groundbreaking solutions across different industries​.

BBVA has a strong presence in the venture capital space through its BBVA Spark and Propel Venture Partners. BBVA Spark, launched in 2023, is focused on supporting high-growth companies, offering a range of financial products and services tailored to the needs of startups and scaleups. BBVA Spark integrates the bank’s Open Innovation initiatives to foster connections within the entrepreneurial ecosystem, facilitating collaborations between startups and established companies. Since its inception, BBVA Spark has invested €200 million in venture capital funds and provided over €100 million in financing across Spain and Mexico, supporting nearly 500 companies. Propel Venture Partners, established in 2016, is another key component of BBVA's venture capital strategy. Propel focuses on fintech and insurtech investments, with notable portfolio companies like Coinbase, Hippo, and Neon. BBVA has committed over $400 million to Propel, which helps bridge the gap between innovative fintech startups and growth opportunities in the Americas and beyond​.

PsyMed Ventures is a venture capital firm focused on transforming mental health treatment through innovative technologies, particularly in the areas of psychedelic medicine, neurotechnology, and precision psychiatry. Founded in 2020 by Dina Burkitbayeva, Greg Kubin, and Matias Serebrinsky, PsyMed Ventures began as a syndicate and has since evolved into a dedicated venture fund. In 2022, the firm launched a $25 million fund aimed at supporting early-stage startups that are pioneering new approaches to mental health. The fund's investments span a range of groundbreaking companies, including Freedom Biosciences and Delix Therapeutics, both of which are exploring the therapeutic potential of psychedelics. PsyMed's portfolio also includes companies working on advanced digital health platforms, novel drug formulations, and innovative neurotechnologies. PsyMed Ventures is particularly interested in companies at the pre-seed, seed, and Series A stages, believing that these early phases are where they can make the most significant impact. The firm emphasizes the importance of aligning with values-driven investors and entrepreneurs, recognizing that the mental health space requires long-term commitment and a collaborative approach.

Purple Orange Ventures (POV) is a Berlin-based, entrepreneur-led impact seed fund founded in 2012 by Gary Lin. Focused on leveraging science and technology, the fund is dedicated to solving some of the world’s most pressing challenges, specifically aiming to remove animals from the global food system and ensure sustainable food production. POV targets early-stage startups that are pioneering food-tech, agri-tech, and biotech innovations across the globe. POV invests primarily in pre-seed, seed, and Series A stages, with typical investments ranging from €100K to €1.5M. The fund backs mission-driven founders developing technologies in areas such as plant-based foods, lab-grown meat, and sustainable agriculture. Its portfolio includes companies like BLUU Seafood (lab-grown fish), Omni (plant-based pet food), and Change Foods (animal-free dairy). These startups are transforming the food industry by offering sustainable alternatives to traditional animal products. In addition to financial backing, Purple Orange Ventures provides its portfolio companies with business development support, operational expertise, and access to a network of industry experts to help accelerate growth and achieve market leadership. The firm’s mission reflects its commitment to creating a more sustainable, animal-free food ecosystem, positioning itself as a leader in the alternative protein and food technology sectors.

Q Venture Partners is a venture capital firm established in 2016, headquartered in Hong Kong. The firm specializes in early-stage investments, particularly focusing on industries like consumer electronics, Internet of Things (IoT), artificial intelligence, and healthcare technologies. Q Venture Partners has a global outlook, investing primarily in North American and Asian markets, with a particular emphasis on scalable technologies that have the potential to transform industries. Led by co-founders Henry Tan and Larry Tsai, the firm adopts a hands-on approach, providing strategic guidance and support to its portfolio companies. The firm's investment strategy is focused on sectors where technology can create significant value, driving both innovation and market disruption. Notable investments include companies like StrongArm Tech, AREVO, and Preteckt, which are leaders in their respective fields of wearable technology, advanced manufacturing, and predictive maintenance software. Q Venture Partners is actively seeking new investments and typically participates in Series A and B funding rounds, often collaborating with other leading venture capital firms. The firm has a track record of successful exits, including the merger of AREVO in 2024, reflecting its ability to identify and nurture high-potential startups into market leaders.

Qiming Venture Partners USA, launched in 2017, focuses on early-stage investments in healthcare, particularly therapeutics and healthcare technologies, across the U.S. and Europe. Backed by its China-based parent firm Qiming Venture Partners, the U.S. arm leverages both financial and human capital to support transformative innovations in healthcare, including drug development and digital health solutions. With over $550 million raised across three funds, Qiming USA has already invested in more than 30 companies and achieved notable exits through M&A and IPOs. Their strategy is centered on partnering with visionary healthcare entrepreneurs, offering not just capital but also deep technical expertise and a global network, including synergies with the broader Qiming platform in China. Key team members include managing partners like Mark McDade and the recent addition of Isaac Ciechanover, whose extensive background in biotech strengthens Qiming’s healthcare focus. Their third fund, closed at $260 million in 2022, continues to invest in innovative therapeutics and health tech ventures that have the potential to make a significant impact on patient outcomes​.

Qualcomm Ventures, founded in 2000, is the corporate venture capital arm of Qualcomm Incorporated, headquartered in San Diego, California. The firm focuses on investing in early to growth-stage companies in sectors such as artificial intelligence (AI), automotive, mobile, enterprise and cloud, and smart systems. It supports startups with strategic guidance, leveraging Qualcomm’s extensive technological expertise and global network. Notable investments from Qualcomm Ventures include companies like Cloudflare, Xiaomi, Zoom, and SentinelOne. These companies have achieved significant milestones, including successful IPOs and high-profile acquisitions. For instance, SentinelOne went public in June 2021, and Zoom became a key player in cloud video conferencing and communication services. Qualcomm Ventures manages over $2 billion in assets and has a portfolio of more than 360 companies, with 22 unicorns and 19 companies that have gone public. The firm is also active in fostering innovation through specific funds like the Qualcomm Ventures AI Fund and the 5G Ecosystem Fund, which target emerging technologies in AI, machine learning, and 5G solutions. The investment team is composed of experienced professionals located in various global regions, including the US, China, and Israel, ensuring a broad and strategic reach to identify and support high-potential startups worldwide​.

Quantonation is a pioneering venture capital fund focused on early-stage investments in quantum technologies and deep physics. Founded in 2018, the Paris-based fund is dedicated to supporting startups working in quantum computing, quantum communications, quantum sensing, and related fields, aiming to accelerate the commercial adoption of groundbreaking scientific innovations. With over €91 million raised in its first fund, Quantonation has backed more than 30 companies, including notable names like Pasqal, ORCA Computing, and Qubit Pharmaceuticals. The fund's strategy targets startups at the pre-seed and seed stages, emphasizing those with the potential to transition quantum innovations into practical, industry-ready applications. These companies address critical areas such as molecular design, high-performance computing, and cybersecurity, with broader impacts expected in fields like healthcare, energy, and climate change mitigation. Quantonation leverages its deep scientific expertise and global network of research institutions, including partnerships with MIT, Ecole Polytechnique, and Oxford University. Quantonation has recently launched its second fund, Quantonation II, with a target of €200 million, signaling its commitment to expanding its support for quantum startups worldwide. Led by a team of experienced scientists and investors like Christophe Jurczak and Olivier Tonneau, the firm is actively shaping the future of the quantum tech ecosystem.

Radian Capital is a growth equity firm founded in 2016, based in New York City. Specializing in business-to-business (B2B) software and technology-enabled services, Radian focuses on helping companies scale by leveraging advanced sales, marketing, and operational techniques. They typically make investments ranging from $5 million to $30 million, targeting businesses with proven models that are poised for rapid growth. Radian's investment strategy centers around accelerating expansion-stage companies, often stepping in to support businesses that already generate significant revenue. Notable portfolio companies include MURAL, a visual collaboration platform, GreyNoise, a cybersecurity intelligence firm, and Niche, a school search platform. These investments reflect Radian’s emphasis on data-driven and tech-enabled industries. The firm recently closed a $500 million third fund, underscoring its increasing presence in the growth equity space. Radian typically looks for companies with innovative, scalable business models and seeks to partner closely with founders. They focus primarily on the U.S. market but are open to international opportunities. Co-founders Jordan Bettman and Weston Gaddy lead the firm, bringing extensive experience in venture and private equity. The team prides itself on being highly involved with their portfolio companies, providing more than just capital by offering strategic guidance to drive significant long-term value. Startups interested in partnering with Radian are encouraged to demonstrate strong market fit, robust unit economics, and a clear path to scaling​.

Radicle Growth, now operating as Clay Capital, is a venture capital firm focused on early-stage investments in agriculture and food technologies. Founded in San Diego, California, Radicle Growth aims to identify and support innovative entrepreneurs and technologies that can transform the food system. They frequently collaborate with global industry leaders to host challenges that fund groundbreaking agtech and foodtech startups. Notable investments by Radicle Growth include MycoTechnology, BlueNalu, Pluton Biosciences, and Phospholutions. MycoTechnology, a pioneer in fungal fermentation, won the $1 million growth-stage investment in the Radicle Protein Challenge by Syngenta. BlueNalu, focused on cell-based seafood, secured a $250,000 early-stage investment in the same challenge. Pluton Biosciences and Phospholutions were the winners of the Radicle Carbon & Soil Challenge by UPL, receiving $1 million and $250,000 respectively, to advance their innovative solutions in carbon sequestration and sustainable phosphorus use. Radicle Growth’s strategy involves not only funding but also providing startups with access to their extensive network of agriculture experts and global connections to accelerate development and promote their technologies. The firm’s commitment to sustainable agriculture is reflected in its continuous efforts to drive innovation and support the development of climate-positive solutions in the food value chain.

Rainfall Ventures is a founder-focused venture capital firm with a strong presence in New York and Los Angeles. Founded in 2011, the firm emphasizes partnering with innovative and passionate founders to help them transform industries. Rainfall Ventures typically invests in early-stage companies, including pre-seed, seed, and Series A rounds, with investment sizes ranging from $1 million to $5 million​. The firm focuses on a broad range of sectors such as analytics, AI, cloud infrastructure, social media, cryptocurrency, cybersecurity, developer tools, digital health, education, fintech, gaming, IoT, and more. This diverse investment strategy allows Rainfall to support a variety of technological advancements and innovative business models. Rainfall Ventures has a portfolio that includes notable companies like Kyra and Blloc, and they invest globally with a particular focus on the US and the UK. The firm has built a reputation for not only providing capital but also offering extensive support to their portfolio companies through mentorship and strategic guidance. The team at Rainfall Ventures includes experienced professionals like co-founder and General Partner Ron Rofé, who bring a wealth of knowledge and expertise to their investment strategy.

Raiven Capital is a global venture capital firm that focuses on early-stage investments, primarily in the areas of Artificial Intelligence (AI), Internet of Things (IoT), and other digital technologies. Founded in 2018, the firm operates with a cross-border strategy, connecting ecosystems between North America, Europe, the Middle East, and Asia. With headquarters in Toronto and additional offices in Palo Alto, Dubai, and London, Raiven Capital seeks to support scalable startups that are leveraging technology to drive significant efficiencies and transformations across various industries. Raiven Capital is known for its hands-on approach, working closely with portfolio companies to help them achieve rapid growth. The firm invests in pre-Series A and Series A companies, providing not just capital, but also strategic guidance, market insights, and access to an extensive global network of industry experts and potential partners. In addition to financial backing, Raiven Capital is deeply involved in the operational aspects of its portfolio companies, helping them navigate challenges and capitalize on opportunities. This approach is aligned with the firm's broader mission to foster innovation that leads to meaningful societal impact, particularly through the deployment of AI and IoT technologies.

Recursive Ventures is a venture capital firm based in San Francisco, focusing on pre-seed and seed investments in tech startups that leverage data and artificial intelligence. Founded by Itamar Novick, Recursive Ventures is known for its nimble and founder-friendly approach, offering strategic guidance and operational support alongside capital. The firm typically invests between $300K and $500K initially, with the capacity to invest up to $1.5M over the lifetime of a company. Recursive Ventures has a diverse portfolio that includes companies across various sectors such as fintech, SaaS, AI, proptech, and insurance tech. Notable companies in their portfolio include DataJoy, Armory, and Life360, with several successful exits and IPOs highlighting their investment success. Recursive Ventures distinguishes itself by moving quickly and making decisions in days rather than weeks, ensuring minimal disruption to founders. They focus on helping startups secure subsequent funding rounds and leverage a vast network of top VC firms globally to support their portfolio companies.

Red Dot Capital Partners, established in 2016 and based in Savyon, Israel, is a growth-stage venture capital firm that focuses on Israeli technology startups. The fund typically invests in companies that have achieved product-market fit, particularly at late Series A to Series C stages, with check sizes ranging from $10 to $20 million. Red Dot is known for leading rounds and plays an active role in guiding portfolio companies through global expansion, particularly into South East Asia and Japan. Their sector-agnostic approach allows them to support companies across various industries, with notable investments in Global-e (cross-border eCommerce), Armis (IoT security), and Granulate (performance optimization). The firm emphasizes working closely with founders, often taking board seats to provide hands-on operational and strategic support throughout the startup's growth journey. Led by co-founders Yaniv Stern and Yoram Oron, Red Dot's team brings decades of experience in venture capital, tech, and global market expansion. They prioritize helping Israeli companies scale internationally, leveraging their network to drive success in new markets.

Redline Capital Management, founded in 2014 and headquartered in London, is a global venture capital and growth equity firm. The firm invests in fast-growing companies with differentiated technologies across North America, Europe, and Israel. Redline's investment focus includes sectors such as security and data, enterprise software, internet and cloud, fintech and e-commerce, AI and robotics, and life science technologies. Redline supports companies through all stages of their development, offering strategic guidance and leveraging their extensive industry experience. Some notable investments include Prosimo, Balbix, and Voltron Data. The firm has successfully exited from several companies, including ZeroFOX, Innovium, and Si-Bone, demonstrating a strong track record in scaling and realizing value from their portfolio companies. The leadership team at Redline Capital includes CEO Tatiana Evtushenkova and Managing Directors such as Dmytro Zakurnaiev and Alastair Cookson. They have built a robust portfolio and continue to back strong management teams driving innovation and growth in their respective sectors.

REV Venture Partners, founded in 2000 and based in London, is a venture capital firm that invests in early-stage technology companies. Backed by RELX Group, a global provider of information-based analytics and decision tools, REV focuses on sectors such as big data, analytics, healthcare information, software, mobile platforms, and internet technologies. Notable investments by REV Venture Partners include companies like Palantir Technologies, a leader in data analytics which went public on the NYSE; EdCast, an AI-powered knowledge cloud for personalized learning, acquired by Cornerstone; and Signal Media, an AI company specializing in media monitoring and business intelligence. Other significant investments include Agworld, a global platform for farm management, and CreativeLive, an educational platform acquired by Fiverr. The firm has a strong track record of successful exits. For example, they have seen acquisitions of companies like iPhrase by IBM, Siperian by Informatica, and Business.com by RH Donnelly. REV continues to leverage its extensive network and deep industry expertise to support portfolio companies in transforming their respective markets through innovative data and technology applications. Led by experienced professionals such as co-founding partners Tony Askew and Kevin Brown, REV Venture Partners maintains a collaborative and hands-on approach to venture investing, providing strategic support and resources to foster growth and success in the companies they back.